99 related articles for article (PubMed ID: 9548461)
1. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.
Inoue S; Kontani K; Tsujimoto N; Kanda Y; Hosoda N; Hoshino S; Hazeki O; Katada T
J Immunol; 1997 Dec; 159(11):5226-32. PubMed ID: 9548461
[TBL] [Abstract][Full Text] [Related]
2. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain.
Kitanaka A; Suzuki T; Ito C; Nishigaki H; Coustan-Smith E; Tanaka T; Kubota Y; Campana D
J Immunol; 1999 Feb; 162(4):1952-8. PubMed ID: 9973464
[TBL] [Abstract][Full Text] [Related]
3. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.
Konopleva M; Estrov Z; Zhao S; Andreeff M; Mehta K
J Immunol; 1998 Nov; 161(9):4702-8. PubMed ID: 9794400
[TBL] [Abstract][Full Text] [Related]
4. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
Kitanaka A; Ito C; Coustan-Smith E; Campana D
J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction via the CD38/NAD+ glycohydrolase.
Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T
Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of chemotactic peptide-induced superoxide generation by CD38 ligation in human myeloid cell lines.
Tsujimoto N; Kontani K; Inoue S; Hoshino S; Hazeki O; Malavasi F; Katada T
J Biochem; 1997 May; 121(5):949-56. PubMed ID: 9192738
[TBL] [Abstract][Full Text] [Related]
7. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
Lund FE; Yu N; Kim KM; Reth M; Howard MC
J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells.
Kontani K; Kukimoto I; Nishina H; Hoshino S; Hazeki O; Kanaho Y; Katada T
J Biol Chem; 1996 Jan; 271(3):1534-7. PubMed ID: 8576149
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45.
Rankin BM; Yocum SA; Mittler RS; Kiener PA
J Immunol; 1993 Jan; 150(2):605-16. PubMed ID: 8419492
[TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes.
Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL
J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395
[TBL] [Abstract][Full Text] [Related]
11. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
12. Induction of CD38/NADase and its monoclonal antibody-induced tyrosine phosphorylation in human leukemia cell lines.
Kontani K; Kukimonto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Katada T
Biochem Biophys Res Commun; 1996 May; 222(2):466-71. PubMed ID: 8670228
[TBL] [Abstract][Full Text] [Related]
13. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma.
Ellis JH; Barber KA; Tutt A; Hale C; Lewis AP; Glennie MJ; Stevenson GT; Crowe JS
J Immunol; 1995 Jul; 155(2):925-37. PubMed ID: 7608568
[TBL] [Abstract][Full Text] [Related]
14. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells.
Yamashita Y; Miyake K; Kikuchi Y; Takatsu K; Noda S; Kosugi A; Kimoto M
Immunology; 1995 Jun; 85(2):248-55. PubMed ID: 7642213
[TBL] [Abstract][Full Text] [Related]
16. Nuclear CD38 in retinoic acid-induced HL-60 cells.
Yalcintepe L; Albeniz I; Adin-Cinar S; Tiryaki D; Bermek E; Graeff RM; Lee HC
Exp Cell Res; 2005 Feb; 303(1):14-21. PubMed ID: 15572023
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS
J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576
[TBL] [Abstract][Full Text] [Related]
18. IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgD-positive B lymphocytes.
Mizoguchi C; Uehara S; Akira S; Takatsu K
J Immunol; 1999 Mar; 162(5):2812-9. PubMed ID: 10072528
[TBL] [Abstract][Full Text] [Related]
19. Signaling through CD38 induces NK cell activation.
Mallone R; Funaro A; Zubiaur M; Baj G; Ausiello CM; Tacchetti C; Sancho J; Grossi C; Malavasi F
Int Immunol; 2001 Apr; 13(4):397-409. PubMed ID: 11282979
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling.
Izadi KD; Erdreich-Epstein A; Liu Y; Durden DL
Exp Cell Res; 1998 Dec; 245(2):330-42. PubMed ID: 9851874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
